Published in Am J Transplant on June 01, 2007
Adult-to-Adult Living Donor Transplant Cohort Study (A2ALL-2) | NCT01619475
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol (2011) 3.36
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology (2011) 2.01
Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL). J Hepatol (2014) 1.56
Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl (2014) 1.54
Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients. Dig Dis Sci (2015) 1.42
Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation. Ann Surg Oncol (2010) 1.25
Live donors in liver transplantation. Gastroenterology (2008) 1.17
Current management of hepatocellular carcinoma. World J Gastroenterol (2014) 1.14
Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. Am J Transplant (2012) 1.10
Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies. Therap Adv Gastroenterol (2010) 1.10
Health-related quality of life of 256 recipients after liver transplantation. World J Gastroenterol (2012) 1.07
Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies. Liver Cancer (2012) 0.99
Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma. World J Hepatol (2014) 0.90
Hepatocellular Carcinoma and Liver Transplantation: State of the Art. J Clin Transl Hepatol (2014) 0.90
Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era. Dig Dis Sci (2011) 0.88
Liver transplantation for alcohol-related cirrhosis: a single centre long-term clinical and histological follow-up. Dig Dis Sci (2010) 0.87
Deceased-donor split-liver transplantation in adult recipients: is the learning curve over? J Am Coll Surg (2013) 0.87
Liver transplantation for hepatocellular carcinoma. World J Gastroenterol (2009) 0.86
Management of hepatocellular carcinoma: Enlightening the gray zones. World J Hepatol (2013) 0.83
The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma. PLoS One (2014) 0.82
Liver Transplantation for HCC: A Review. Indian J Surg (2011) 0.82
Management of recurrent hepatocellular carcinoma after liver transplant. World J Hepatol (2015) 0.81
Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation. World J Gastroenterol (2013) 0.81
Liver transplantation as a management of hepatocellular carcinoma. World J Hepatol (2015) 0.80
Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence. Ann Gastroenterol (2015) 0.79
Medical treatment of hepatocellular carcinoma. Mediterr J Hematol Infect Dis (2009) 0.79
Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation. World J Gastroenterol (2014) 0.78
Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter. HPB (Oxford) (2014) 0.78
Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation. PLoS One (2013) 0.78
Liver transplantation for hepatic tumors: a systematic review. World J Gastroenterol (2014) 0.78
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol (2017) 0.78
Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World J Gastroenterol (2016) 0.77
A review of current status of living donor liver transplantation. Hepatobiliary Surg Nutr (2016) 0.77
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int (2017) 0.77
Recent advances in liver transplantation for the practicing gastroenterologist. Gastroenterol Hepatol (N Y) (2009) 0.76
The long-term outcomes of patients with hepatocellular carcinoma after living donor liver transplantation: a comparison of right and left lobe grafts. Surg Today (2012) 0.76
Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison. World J Gastroenterol (2014) 0.75
The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation. Theranostics (2016) 0.75
Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors? Int J Organ Transplant Med (2013) 0.75
Optimal treatment for hepatocellular carcinoma in the cirrhotic liver. Ann R Coll Surg Engl (2009) 0.75
Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome. ISRN Hepatol (2014) 0.75
Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria. Indian J Surg (2014) 0.75
Liver transplantation for hepatocellular carcinoma from living-donor vs. deceased donor. Hepatobiliary Surg Nutr (2016) 0.75
Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma. Transl Gastroenterol Hepatol (2016) 0.75
Twenty years of Milan criteria and live-donor liver transplantation in the US: a contrast in transparency, regulation, and expectation. Hepatobiliary Surg Nutr (2016) 0.75
Liver transplantation for small hepatocellular carcinoma. Hepatobiliary Surg Nutr (2016) 0.75
Living donor liver transplantation: eliminating the wait for death in end-stage liver disease? Nat Rev Gastroenterol Hepatol (2017) 0.75
Recurrence of hepatocellular carcinoma after living donor liver transplantation: what is the current optimal approach to prevent recurrence? World J Surg (2011) 0.75
Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores. Surg Today (2013) 0.75
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer (1954) 12.77
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl (2005) 2.56
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28
Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl (2003) 2.04
Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology (2006) 1.93
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88
Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg (2004) 1.59
Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Hepatology (2001) 1.53
Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl (2006) 1.48
Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology (2004) 1.45
Liver transplantation for hepatocellular carcinoma. Gastroenterology (2004) 1.24
The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl (2004) 1.20
American Society of Transplant Surgeons' position paper on adult-to-adult living donor liver transplantation. Liver Transpl (2000) 0.98
Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant (2004) 0.98
The quandary over liver transplantation for hepatocellular carcinoma: the greater sin? Liver Transpl (2002) 0.87
Structure of yeast phenylalanine tRNA at 3 A resolution. Nature (1974) 10.27
New rapid gel sequencing method for RNA. Nature (1977) 9.56
Structure of nucleosome core particles of chromatin. Nature (1977) 6.24
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
The primary structure of transcription factor TFIIIA has 12 consecutive repeats. FEBS Lett (1985) 4.73
Structure of yeast phenylalanine transfer RNA at 2.5 A resolution. Proc Natl Acad Sci U S A (1975) 4.57
The crystal structure of EcoRV endonuclease and of its complexes with cognate and non-cognate DNA fragments. EMBO J (1993) 4.11
Development of the new lung allocation system in the United States. Am J Transplant (2006) 4.02
Outcomes of stroke patients in Medicare fee for service and managed care. JAMA (1997) 3.91
A crystallographic study of metal-binding to yeast phenylalanine transfer RNA. J Mol Biol (1977) 3.71
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant (2009) 3.09
Estimating hospital costs. A multiple-output analysis. J Health Econ (1986) 3.09
Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med (1979) 2.82
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78
Current methods of transfer of young people with Type 1 diabetes to adult services. Diabet Med (2002) 2.76
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Further refinement of the structure of yeast tRNAPhe. J Mol Biol (1978) 2.71
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant (2008) 2.63
Degradation of collagen by a human granulocyte collagenolytic system. J Clin Invest (1968) 2.62
The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet (1968) 2.61
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. Clin Oncol (R Coll Radiol) (2001) 2.41
Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest (1999) 2.29
Animal research in liver transplantation with special reference to the dog. Semin Liver Dis (1985) 2.28
World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat (2002) 2.26
Crystallographic and biochemical investigation of the lead(II)-catalyzed hydrolysis of yeast phenylalanine tRNA. Biochemistry (1985) 2.22
Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation. Arch Surg (2000) 2.09
Alfentanil for conscious sedation during colonoscopy. South Med J (1995) 2.07
Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of life. Liver Transpl (2001) 2.06
Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med (1977) 2.06
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04
Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant (2008) 2.04
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Low flow venovenous bypasses in small dogs and pediatric patients undergoing replacement of the liver. Surg Gynecol Obstet (1986) 2.00
Variation in organ quality between liver transplant centers. Am J Transplant (2011) 1.99
A model for the tertiary structure of the 28 residue DNA-binding motif ('zinc finger') common to many eukaryotic transcriptional regulatory proteins. Protein Eng (1988) 1.98
Atomic co-ordinates for yeast phenylalanine tRNA. Nucleic Acids Res (1975) 1.98
Pb(II)-catalysed cleavage of the sugar-phosphate backbone of yeast tRNAPhe--implications for lead toxicity and self-splicing RNA. Nature (1983) 1.92
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
X-ray diffraction study of a new crystal form of the nucleosome core showing higher resolution. J Mol Biol (1981) 1.81
Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant (2008) 1.69
Human granulocyte collagenase. Science (1968) 1.68
Differing roles for zinc fingers in DNA recognition: structure of a six-finger transcription factor IIIA complex. Proc Natl Acad Sci U S A (1998) 1.67
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med (1995) 1.67
The home health visit: an appropriate unit for Medicare payment? Health Aff (Millwood) (1996) 1.67
Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation. Cancer J Sci Am (2006) 1.64
Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study. J Clin Endocrinol Metab (2014) 1.63
Fatal Clostridium difficile enteritis after total abdominal colectomy. J Clin Gastroenterol (1996) 1.63
Kallmann syndrome: MR findings. AJNR Am J Neuroradiol (1993) 1.60
Fingers and helices. Nature (1987) 1.59
Adult living donor liver transplantation using a right hepatic lobe. Transplantation (1998) 1.59
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Correlation between three-dimensional structure and chemical reactivity of transfer RNA. Nucleic Acids Res (1974) 1.58
Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) (1991) 1.56
Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet (1991) 1.55
Liver transplantation in children. Ann Surg (1991) 1.51
Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies. J Nucl Med (2000) 1.51
Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate. Hepatology (2000) 1.50
More on the contraindications to vasoconstrictors in dentistry. Oral Surg Oral Med Oral Pathol (1993) 1.46
Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant (2009) 1.42
Comparison of Gianturco Z stents and Wallstents in a hemodialysis access graft animal model. J Vasc Interv Radiol (1995) 1.42
Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Liver Transpl Surg (1999) 1.42
A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats. Transplantation (1992) 1.40
Workers' compensation introduction for physicians. Va Med Q (1995) 1.40
The future of dentistry. Dent Today (2001) 1.40
Symptomatic non-insulin-dependent diabetes mellitus during therapy with recombinant human growth hormone. J Pediatr (1993) 1.38
Adult-to-adult living donor liver transplantation using right-lobe grafts: results and lessons learned from a single-center experience. Liver Transpl (2001) 1.38
Purification and crystallization of the EcoRV restriction endonuclease. J Biol Chem (1985) 1.37
Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl (2001) 1.35
Treatment of PTLD with rituximab or chemotherapy. Am J Transplant (2006) 1.33
Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant (2012) 1.32
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology (2007) 1.31
Use of extreme position changes in acute respiratory failure. Crit Care Med (1976) 1.31
House staff attitudes toward teaching. J Med Educ (1970) 1.30
Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology (1987) 1.30
Cardiovascular function in shock. Responses to volume loading and isoproterenol infusion. Circulation (1967) 1.26
Why do so few HMOs offer Medicare risk plans in rural areas? Health Care Financ Rev (1995) 1.26
Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation (2007) 1.26
Do preset per visit payment rates affect home health agency behavior? Health Care Financ Rev (1994) 1.25
Regional variability in symptom-based MELD exceptions: a response to organ shortage? Am J Transplant (2011) 1.25
Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology (1987) 1.24
Role of renal prostaglandins during antidiuresis and water diuresis in man. Kidney Int (1982) 1.24